Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

202 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
HLA and hepatitis B infection.
Almarri A, Batchelor JR. Almarri A, et al. Among authors: batchelor jr. Lancet. 1994 Oct 29;344(8931):1194-5. doi: 10.1016/s0140-6736(94)90510-x. Lancet. 1994. PMID: 7934542
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.
Batchelor JR, Welsh KI, Tinoco RM, Dollery CT, Hughes GR, Bernstein R, Ryan P, Naish PF, Aber GM, Bing RF, Russell GI. Batchelor JR, et al. Lancet. 1980 May 24;1(8178):1107-9. doi: 10.1016/s0140-6736(80)91554-8. Lancet. 1980. PMID: 6103441
HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ. Wooley PH, et al. Among authors: batchelor jr. N Engl J Med. 1980 Aug 7;303(6):300-2. doi: 10.1056/NEJM198008073030602. N Engl J Med. 1980. PMID: 6770269
HLA genetic determinants in familial MS. A study from the Grampian region of Scotland.
Francis DA, Batchelor JR, McDonald WI, Dodi IA, Hing SN, Hern JE, Downie AW. Francis DA, et al. Among authors: batchelor jr. Tissue Antigens. 1987 Jan;29(1):7-12. Tissue Antigens. 1987. PMID: 3590146
Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ?
Francis DA, Thompson AJ, Brookes P, Davey N, Lechler RI, McDonald WI, Batchelor JR. Francis DA, et al. Among authors: batchelor jr. Hum Immunol. 1991 Oct;32(2):119-24. doi: 10.1016/0198-8859(91)90108-l. Hum Immunol. 1991. PMID: 1683865
Interferon-alpha therapy in HCV hepatitis: HLA phenotype and cirrhosis are independent predictors of clinical outcome.
Almarri A, El Dwick N, Al Kabi S, Sleem K, Rashed A, Ritter MA, Batchelor JR. Almarri A, et al. Among authors: batchelor jr. Hum Immunol. 1998 Apr;59(4):239-42. doi: 10.1016/s0198-8859(98)00010-x. Hum Immunol. 1998. PMID: 9568799
Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia.
Goldman JM, Baughan AS, McCarthy DM, Worsley AM, Hows JM, Gordon-Smith EC, Catovsky D, Batchelor JR, Goolden AW, Galton DA. Goldman JM, et al. Among authors: batchelor jr. Lancet. 1982 Sep 18;2(8299):623-5. doi: 10.1016/s0140-6736(82)92736-2. Lancet. 1982. PMID: 6125773
Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus.
Speirs C, Fielder AH, Chapel H, Davey NJ, Batchelor JR. Speirs C, et al. Among authors: batchelor jr. Lancet. 1989 Apr 29;1(8644):922-4. doi: 10.1016/s0140-6736(89)92506-3. Lancet. 1989. PMID: 2565418
Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation.
Schwarer AP, Jiang YZ, Brookes PA, Barrett AJ, Batchelor JR, Goldman JM, Lechler RI. Schwarer AP, et al. Among authors: batchelor jr. Lancet. 1993 Jan 23;341(8839):203-5. doi: 10.1016/0140-6736(93)90067-q. Lancet. 1993. PMID: 8093498
HL-A matching in treatment of burned patients with skin allografts.
Batchelor JR, Hackett M. Batchelor JR, et al. Lancet. 1970 Sep 19;2(7673):581-3. doi: 10.1016/s0140-6736(70)90165-0. Lancet. 1970. PMID: 4195544 Clinical Trial. No abstract available.
202 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page